Literature DB >> 16367904

Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas.

Shuichi Mitsunaga1, Takahiro Hasebe, Motoki Iwasaki, Taira Kinoshita, Atsushi Ochiai, Nobuyoshi Shimizu.   

Abstract

For clinicians, the orthodox histological investigation of patients with invasive ductal carcinoma (IDC) remains important for predicting prognoses. The purpose of the present study was to determine the most important of the known prognostic histological parameters (including fibrotic focus and tumor necrosis), enabling the outcomes of 101 patients with IDC of the pancreas to be predicted accurately. Furthermore, we established a scoring classification consisting of important prognostic histological parameters examined in this study. Multivariate survival analyses showed that invasive tumor size of more than 3 cm, the presence of tumor necrosis, the presence of nerve plexus invasion and lymph vessel invasion scores of 2 or 3 were important prognostic factors. Our scoring classification, consisting of the above four parameters, accurately classified the outcome of patients independent of the invasive tumor size of IDC. We concluded that invasive tumor size of 3 cm or more, the presence of tumor necrosis, the presence of nerve plexus invasion and lymph vessel invasion scores of 2 or 3 are important histological prognostic parameters for patients with IDC of the pancreas. Furthermore, the scoring system consisting of the above four histological parameters is probably a very useful prognostic histological classification for patients with IDC of the pancreas. (Cancer Sci 2005; 96: 858 - 865).

Entities:  

Mesh:

Year:  2005        PMID: 16367904     DOI: 10.1111/j.1349-7006.2005.00128.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  12 in total

1.  PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker.

Authors:  Sayaka Yuzawa; Mitsunobu R Kano; Takahiro Einama; Hiroshi Nishihara
Journal:  Med Oncol       Date:  2012-03-09       Impact factor: 3.064

2.  Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.

Authors:  Min Shi; Dang-Hui Yu; Ying Chen; Chen-Yan Zhao; Jing Zhang; Qing-Hua Liu; Can-Rong Ni; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

3.  The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.

Authors:  Hisataka Ogawa; Hiroaki Nagano; Masamitsu Konno; Hidetoshi Eguchi; Jun Koseki; Koichi Kawamoto; Naohiro Nishida; Hugh Colvin; Akira Tomokuni; Yoshito Tomimaru; Naoki Hama; Hiroshi Wada; Shigeru Marubashi; Shogo Kobayashi; Masaki Mori; Yuichiro Doki; Hideshi Ishii
Journal:  Mol Clin Oncol       Date:  2015-01-22

4.  Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen W Behrman; Edgar Ben-Josef; Al B Benson; Ephraim S Casper; Steven J Cohen; Brian Czito; Joshua D I Ellenhorn; William G Hawkins; Joseph Herman; John P Hoffman; Andrew Ko; Srinadh Komanduri; Albert Koong; Wen Wee Ma; Mokenge P Malafa; Nipun B Merchant; Sean J Mulvihill; Peter Muscarella; Eric K Nakakura; Jorge Obando; Martha B Pitman; Aaron R Sasson; Anitra Tally; Sarah P Thayer; Samuel Whiting; Robert A Wolff; Brian M Wolpin; Deborah A Freedman-Cass; Dorothy A Shead
Journal:  J Natl Compr Canc Netw       Date:  2012-06-01       Impact factor: 11.908

5.  Histological tumor necrosis in pancreatic cancer after neoadjuvant therapy.

Authors:  Masashi Kudo; Genichiro Ishii; Naoto Gotohda; Masaru Konishi; Shinichiro Takahashi; Shin Kobayashi; Motokazu Sugimoto; John D Martin; Horacio Cabral; Motohiro Kojima
Journal:  Oncol Rep       Date:  2022-05-18       Impact factor: 4.136

6.  Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach.

Authors:  Chang Moo Kang; Dong Hyun Kim; Woo Jung Lee
Journal:  Surg Endosc       Date:  2010-01-07       Impact factor: 4.584

7.  Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation.

Authors:  N Hiraoka; Y Ino; S Sekine; H Tsuda; K Shimada; T Kosuge; J Zavada; M Yoshida; K Yamada; T Koyama; Y Kanai
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

8.  Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for ex vivo Irreversible Electroporation Testing.

Authors:  Rebecca M Brock; Natalie Beitel-White; Sheryl Coutermarsh-Ott; Douglas J Grider; Melvin F Lorenzo; Veronica M Ringel-Scaia; Navid Manuchehrabadi; Robert C G Martin; Rafael V Davalos; Irving C Allen
Journal:  Front Oncol       Date:  2020-05-22       Impact factor: 6.244

9.  Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer.

Authors:  Bo Kong; Tao Cheng; Weiwei Wu; Ivonne Regel; Susanne Raulefs; Helmut Friess; Mert Erkan; Irene Esposito; Jörg Kleeff; Christoph W Michalski
Journal:  Oncotarget       Date:  2015-10-13

Review 10.  Management of pancreatic head adenocarcinoma: From where to where?

Authors:  Kemal Dolay; Fatma Umit Malya; Sami Akbulut
Journal:  World J Gastrointest Surg       Date:  2019-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.